A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of the Sufentanil NanoTab PCA System/15 mcg (Zalvisoâ„¢) for the Treatment of Post-Operative Pain in Patients After Open Abdominal Surgery